e-learning
resources
Berlin 2008
Tuesday, 07.10.2008
Clinical applications of ventilatory function tests in paediatric pulmonology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Infants with recurrent wheeze: lung function and clinical risk factors for asthma
L. M. Borrego, J. Stocks, P. Leiria-Pinto, I. Peralta, A. M. Romeira, N. Neuparth, J. Rosado-Pinto, A. F. Hoo (Lisbon, Portugal; London, United Kingdom)
Source:
Annual Congress 2008 - Clinical applications of ventilatory function tests in paediatric pulmonology
Session:
Clinical applications of ventilatory function tests in paediatric pulmonology
Session type:
Thematic Poster Session
Number:
3897
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. M. Borrego, J. Stocks, P. Leiria-Pinto, I. Peralta, A. M. Romeira, N. Neuparth, J. Rosado-Pinto, A. F. Hoo (Lisbon, Portugal; London, United Kingdom). Infants with recurrent wheeze: lung function and clinical risk factors for asthma. Eur Respir J 2008; 32: Suppl. 52, 3897
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Predicting persistent disease among children who wheeze during early life
Source: Eur Respir J 2003; 22: 767-771
Year: 2003
Expiratory variability index is associated with asthma risk, wheeze and lung function in infants with recurrent respiratory symptoms
Source: ERJ Open Res, 6 (4) 00167-2020; 10.1183/23120541.00167-2020
Year: 2020
Severe bronchial asthma: risk factors
Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond
Year: 2008
Risk factors for recurrent wheezing after viral bronchiolitis - is there a relationship with subsequent asthma?
Source: Eur Respir J 2003; 22: Suppl. 45, 138s
Year: 2003
The coexistence of asthma and COPD: risk factors, clinical history and lung function trajectories
Source: Eur Respir J, 58 (5) 2004656; 10.1183/13993003.04656-2020
Year: 2021
Incidence of asthma and wheeze among teenagers is associated with environmental risk factors
Source: Annual Congress 2012 - Epidemiology of asthma
Year: 2012
Factors predicting the development of asthma in wheezing children
Source: International Congress 2017 – Translational studies of lung disease
Year: 2017
Role of bacterial infection in preschool wheeze: a risk factor for persistent wheeze and a reason for treatment failure?
Source: International Congress 2015 – Preschool wheeze: new insights
Year: 2015
Risk factors for severe asthma among adults with asthma
Source: Virtual Congress 2020 – Diagnosis and management of asthma
Year: 2020
Prediction of the risk of future exacerbations in patients with severe persistent allergic asthma
Source: Annual Congress 2005 - Severe asthma: perception and management
Year: 2005
Does paracetamol use increase the risk of recurrent wheeze or atopy in young children?
Source: Eur Respir J 2001; 18: Suppl. 33, 523s
Year: 2001
Predicting new-onset of wheeze in adolescence: the role of susceptibility factors assessed in childhood
Source: Annual Congress 2005 - Novelties in asthma progression and risks
Year: 2005
Risk factors for moderate exacerbations in childhood asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 163s
Year: 2004
COPD patients with asthma, characteristics and risk of exacerbations
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
The risk factors in asthma patients for COVID19 infection
Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects
Year: 2021
Prevalence and risk factors of fixed airway obstruction in children with asthma
Source: International Congress 2018 – The bad and the ugly in paediatric asthma: comorbidities and exacerbations
Year: 2018
Transient early wheeze is not associated with impaired lung function in 7-yr-old children
Source: Eur Respir J 2003; 21: 834-841
Year: 2003
The significance of early recurrent wheeze for asthma outcomes in late childhood
Source: Eur Respir J 2013; 41: 838-845
Year: 2013
Risk factors for multimorbidity in wheezing children: role of the phenotype
Source: International Congress 2017 – What is the future for paediatric respiratory physiology and sleep?
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept